Variability of anti-β2 glycoprotein I antibodies measurement by commercial assays: A collaborative study in the frame of the European Forum on Antiphospholipid Antibodies Standardization Group

Thrombosis and Haemostasis

Volumn 94, Issue 3, 2005, Pages 665-672

  Reber, Guido ^a   Tincani, Angela ^b   Sanmarco, Marielle ^c   de Moerloose, Philippe ^a   Boffa, Marie Claire ^d  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b Brescia Civic Hospital   (Italy)

^c HÔPITAL DE LA CONCEPTION   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Anti 2glycoprotein I antibodies; Antiphospholipid antibodies; Assays; Standardization

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; MONOCLONAL ANTIBODY; PHOSPHOLIPID ANTIBODY; AUTOANTIBODY; BETA2 GLYCOPROTEIN 1; GLYCOPROTEIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ANALYTICAL EQUIPMENT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD SAMPLING; CALIBRATION; CALIBRATOR; CLINICAL FEATURE; CONTROLLED STUDY; DILUTION; EUROPE; HEALTH CARE FACILITY; HUMAN; IMMUNOASSAY; MEASUREMENT; PRIORITY JOURNAL; SCORING SYSTEM; STANDARDIZATION; SYSTEMIC LUPUS ERYTHEMATOSUS; BLOOD; COMPARATIVE STUDY; IMMUNOLOGY; PREDICTION AND FORECASTING; SENSITIVITY AND SPECIFICITY; SEROLOGY; STANDARD;

ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREDICTIVE VALUE OF TESTS; REAGENT KITS, DIAGNOSTIC; REFERENCE STANDARDS; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS;

EID: 24944473169     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH05-02-0081     Document Type: Article

References (26)

1. Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite Antiphospholipid syndrome. Arthritis Rheum 1999; 42: 1309-11.
2. Galli M, Luciani D, Bertolini G, et al. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 2003; 101: 1827-32.
3. Galli M, Barbui T. Antiphospholipid antibodies and thrombosis: strength of association. Hematol J 2003; 4: 180-6.
4. Galli M, Barbui T. Antiphospholipid antibodies and pregnancy. Best Pract & Res Clin Haematol 2003; 16: 211-25.
5. Brandt JT, Triplett DA, Alving B, et al. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost 1995; 74: 1185-90.
6. Jennings I, Greaves M, Mackie IJ, et al. Lupus anticoagulant testing: improvements in performance in a UK NEQAS proficiency testing exercise after dissemination of national guidelines on laboratory methods. Br J Haematol 2002; 119: 364-9.
7. Arnout J, Meijer P, Vermylen J. Lupus anticoagulant testing in Europe: an analysis of results from the first European Concerted Action on Thrombophilia (ECAT) survey using plasmas spiked with monoclonal antibodies against human beta2-glycoprotein I. Thromb Haemost 1999; 81: 929-34.
8. Reber G, Arvieux J, Comby E, et al. Multicenter evaluation of nine commercial kits for the quantitation of anticardiolipin antibodies. Thromb Haemost 1995; 73: 444-52.
9. Favaloro EJ, Silvestrini R. Assessing the usefulness of anticardiolipin antibody assays: a cautious approach is suggested by high variation and limited consensus in multilaboratory testing. Am J Clin Pathol 2002; 118: 548-57.
10. Harris EN. The second international anti-cardiolipin standardization workshop/The Kingston antiphospholipid antibody (KAPS) study group. Am J Clin Pathol 1990; 94: 476-84
11. Tincani A, Allegri F, Sanmarco M, et al. Anticardiolipin antibody assay: a methodological analysis for a better consensus in routine determinations. A cooperative project of the European Antiphospholipid Forum. Thromb Haemost 2001; 86: 575-83.
12. Viard JP, Amoura Z, Bach JF. Association of anti-beta 2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus. Am J Med 1992; 93: 181-6.
13. 2-glycoprotein I, antiprothrombin antibodies and the risk of thrombosis in the antiphospholipid syndrome. Blood 2003; 102: 2717-23.
14. Pengo V. Communication. 48th Annual SSC meeting, Boston MA, USA July 18 2002. See annual SSC reports at the ISTH website: http://www.med.unc.edu/isth.
15. Nash MJ, Camilleri RS, Kunka S, et al. The anticardiolipin assay is required for sensitive screening for antiphospholipid antibodies. J Thromb Haemost 2004; 2: 1077-81.
16. 2-glycoprotein I measurement. A collaborative study in the frame of the European forum on antiphospholipid antibodies standardization group. Thromb Haemost 2002; 88: 66-73.
17. 2-glycoprotein I antibodies. Arthritis Rheum 1999; 42: 2461-70.
18. 2-glycoprotein I. J Rheumatol 2000; 27: 391-6.
19. Iverson GM, Matsuura E, Victoria EJ, et al. The orientation of beta2GPI on the plate is important for the binding of anti-beta2GPI autoantibodies by ELISA. J Autoimmunity 2002; 18: 289-97.
20. 2-glycoprotein I in the absence of phospholipids. Importance of antigen density and bivalent binding. J Immunol 1995; 154: 954-60.
21. Reddel SW, Wang YX, Krilis SA. Anti-beta2-glycoprotein I autoantibodies require an antigen density threshold, consistent with divalent binding. Lupus 2003; 12: 37-45.
22. Brighton TA, Dai YP, Hogg PJ, et al. Microheterogeneity of beta-2 glycoprotein I: implications for binding to anionic phospholipids. Biochem J 1999; 340: 59-67.
23. Schousboe I. Characterization of subfractions of beta 2-glycoprotein I: evidence for sialic acid microheterogeneity. Int J Biochem 1983; 15: 35-44.
24. Gries A, Nimpf J, Wurm H, et al. Characterization of isoelectric subspecies of asialo-beta 2-glycoprotein I. Biochem J 1989; 260: 531-4.
25. Audrain MA, Colonna F, Morio F, et al. Comparison of different kits in the detection of autoantibodies to cardiolipin and beta2glycoprotein 1. Rheumatology 2004; 43: 181-5.
26. Reber G, Tincani A, Sanmarco M, et al. Proposals for the measurement of anti-beta2-glycoprotein I antibodies. Standardization group of the European Forum on Antiphospholipid Antibodies. J Thromb Haemost 2004; 2: 1860-2.